MetaVia Inc. — Investor Relations & Filings
Filings indexed
602
across all filing types
Latest filing
2026-05-27
Regulatory Filings
Country
US
United States of America
Listing
US
MTVA
MetaVia Inc. is a clinical-stage biotechnology company focused on developing novel pharmaceuticals for cardiometabolic diseases. The company's pipeline is centered on innovative treatments for obesity and metabolic dysfunction-associated steatohepatitis (MASH). Its lead product candidate, DA-1726, is a dual oxyntomodulin (OXM) analog agonist that functions on both the glucagon-like peptide-1 receptor (GLP1R) and the glucagon receptor (GCGR), under development for obesity. Another key asset is Vanoglipel, a G-Protein-Coupled Receptor 119 (GPR119) agonist being developed for MASH.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-27 | English | |
| 8-K | 2026-05-18 | English | |
| 10-Q | 2026-05-14 | English | |
| 8-K | 2026-05-14 | English | |
| 8-K - MetaVia Inc. (0001638287) (Filer) | 2026-05-11 | English | |
| ARS - MetaVia Inc. (0001638287) (Filer) | 2026-04-27 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47571812 | 8-K | 2026-05-27 | English | ||
| 46385515 | 8-K | 2026-05-18 | English | ||
| 46272697 | 10-Q | 2026-05-14 | English | ||
| 46274604 | 8-K | 2026-05-14 | English | ||
| 44961334 | 8-K - MetaVia Inc. (0001638287) (Filer) | 2026-05-11 | English | ||
| 37387969 | ARS - MetaVia Inc. (0001638287) (Filer) | 2026-04-27 | English | ||
| 37388007 | DEF 14A - MetaVia Inc. (0001638287) (Filer) | 2026-04-27 | English | ||
| 33993571 | 8-K - MetaVia Inc. (0001638287) (Filer) | 2026-04-10 | English | ||
| 33743082 | 424B3 - MetaVia Inc. (0001638287) (Filer) | 2026-04-07 | English | ||
| 33300151 | S-8 - MetaVia Inc. (0001638287) (Filer) | 2026-04-03 | English | ||
| 33048707 | 10-K - MetaVia Inc. (0001638287) (Filer) | 2026-03-26 | English | ||
| 33048686 | 8-K - MetaVia Inc. (0001638287) (Filer) | 2026-03-26 | English | ||
| 32974884 | 8-K - MetaVia Inc. (0001638287) (Filer) | 2026-03-18 | English | ||
| 31051256 | 8-K Filing | 2026-01-27 | English | ||
| 31051221 | 4 Filing | 2026-01-27 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ANHUI FENGYUAN PHARMACEUTICAL CO., LTD
Produces injections, solid dosage forms, APIs, and nutritio…
|
000153 | CN | Manufacturing |
|
Anhui Huangshan Capsule Co.,Ltd
Produces empty hard capsules, including gelatin and HPMC ve…
|
002817 | CN | Manufacturing |
|
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
Develops and manufactures pharmaceutical excipients for sol…
|
300452 | CN | Manufacturing |
|
Anika Therapeutics, Inc.
A global joint preservation company developing solutions fo…
|
ANIK | US | Manufacturing |
|
ANIMALCARE GROUP PLC
Develops and commercializes veterinary pharmaceutical produ…
|
ANCR | GB | Manufacturing |
|
ANI PHARMACEUTICALS INC
Develops, manufactures, and markets branded, generic, and O…
|
ANIP | US | Manufacturing |
|
ANLON HEALTHCARE LIMITED
Researches and manufactures APIs, intermediates, and finish…
|
AHCL | IN | Manufacturing |
|
Annexin Pharmaceuticals AB
Clinical-stage biotech developing a cell-protecting biologi…
|
ANNX | SE | Manufacturing |
|
Annexon, Inc.
Clinical-stage biopharma developing complement medicines by…
|
ANNX | US | Manufacturing |
|
Antengene Corporation Limited
Global biopharma developing and commercializing novel oncol…
|
6996 | KY | Manufacturing |
MetaVia Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34919/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34919 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34919 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34919 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34919}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for MetaVia Inc. (id: 34919)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.